← Back to screener

Praxis Precision Medicines, Inc. PRAX

Rank #2446 · Nasdaq · $8.0B market cap
⚠ Going-concern flag — the auditor (Ernst & Young LLP) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.
Score
17.7
P/E
-64.7
P/B
104.74
ROE
-162.0%
Op. Margin
-5164.4%
Debt Ratio
49%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Poor

P/E -64.7x, P/B 104.74x. Ranks in the top 82% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -162.0%. Ranks in the top 97% of the universe.

Safety ★★★★☆
Good

Debt ratio 49%. Ranks in the top 23% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Weak

Revenue growth of 0.0% year over year. Ranks in the top 65% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2020–$-0.0B$-0.0B$-0.0B–-18
2021–$-0.1B$-0.1B$-0.1B–-19
2022–$-0.2B$-0.2B$0.3B–15
2023$0.0B$-0.2B$-0.2B$0.3B–16
2024$0.0B$-0.1B$-0.1B$0.1B-5164.424
2025$0.0B$-0.1B$-0.1B$0.1B-5164.449

← See the full screener